What is the CYP2D6 gene?
CYP2D6 encodes a liver enzyme that processes many medications and some endogenous compounds. Its activity can vary widely, which changes how long certain compounds remain active.
How CYP2D6 affects metabolism
When CYP2D6 activity is slower or faster than average, clearance can become less predictable. That matters most for medication response, but it also signals that biotransformation differences may deserve more attention.
What happens when CYP2D6 is altered
Altered CYP2D6 function does not create a generic metabolic disorder. It creates practical differences in how compounds are handled, which is why it is best treated as a follow-up and safety pathway.
Common symptoms people report
- unusually strong medication effects
- unexpected side effects from standard doses
- slow recovery after medication changes
- compound sensitivity that feels disproportionate
Biomarkers to validate
Medication response history
Real-world response is often the most meaningful validation signal.
Liver enzymes when relevant
Helpful baseline context when drug metabolism is a concern.
Clinical pharmacogenetic review
May be appropriate when medication decisions depend on CYP2D6 status.
Where DNA analysis helps
DNA is useful here because the pathway has direct practical implications, especially for compound tolerance. The value is in safer follow-up, not broad metabolic storytelling.
Example Insight
Your compound-clearance pathway may process some medications differently from the average pattern.
Suggested validation: medication-response review with clinician support.
What to do next
- Keep this pathway in scope whenever medication sensitivity is part of the picture.
- Use prescribing support when CYP2D6-relevant drugs are involved.
- Treat DNA findings as context to discuss with a qualified clinician, not a self-prescribing tool.
Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.
Get My DNA Report